Skip to main content
Bespoke Mentis
Live: Pharma AI Platform

AI-Powered Clinical Intelligence for Pharmaceutical Organizations

Project Foresight delivers governed signal detection, protocol optimization, regulatory compliance AI, and cross-system clinical data analysis: validated at 96/100 EXCELLENT with SHA-256 audit trails on every output.

Foresight is a product of Mentis Health, a Bespoke Mentis company.

Platform Evidence

Performance Validated Across Six Clinical Cutoffs

60%
Reduction in protocol deviation detection time vs manual review baseline
96/100
Composite governance validation score (EXCELLENT) across 6 frozen cutoffs
100%
Signal detection accuracy in retrospective mCRC therapeutic landscape validation
SHA-256
Cryptographic hash chain on every output: tamper-evident, regulator-ready
14 days
Mean reduction in time from FAERS signal emergence to structured clinical report
0
Knowledge contamination events detected across all frozen validation cutoffs
The Problem

Four Failures Costing Pharma Billions Every Year

The clinical development process is broken in predictable ways. These are not edge cases. They are structural, recurring, and expensive.

Manual Protocol Analysis

Clinical protocol review is performed manually by overstretched research teams. Deviations surface weeks after they occur. Every hour of delay compounds downstream risk.

Protocol deviations detected late cost an average of $600K per incident in CRO delays

Slow Signal Detection

Adverse event signals buried across FAERS, literature, and clinical databases take weeks to surface. By the time analysis is complete, the signal has grown.

Mean time from FAERS signal emergence to detection: 14-28 days with manual review

Regulatory Burden

21 CFR Part 11, GCP compliance, and FDA audit readiness each demand documentation at a scale most clinical teams cannot sustain. Audit gaps accumulate silently.

FDA 483 observations related to data integrity cost on average $1.2M to remediate

Siloed Clinical Data

Trial data sits in disconnected systems: EDC, CTMS, safety databases, and lab systems that never communicate. Cross-functional decisions get made on incomplete pictures.

Data silos add an average of 6-9 months to Phase III trial completion timelines

Platform Capabilities

What Project Foresight Does

Four governed intelligence capabilities designed for the specific failure modes of pharmaceutical clinical development.

Capability

Signal Intelligence

Real-time detection of adverse event signals, competitive pipeline movements, and regulatory flag patterns across FAERS, ClinicalTrials.gov, and global regulatory feeds. Every signal is source-attributed and SHA-256 verified at the moment of detection.

Capability

Protocol Optimization

AI-assisted protocol analysis that compares your design against historical trial outcomes, FDA precedent, and NCCN patterns. Surfaces deviation risk, endpoint selection vulnerability, and inclusion or exclusion criteria gaps before IND submission.

Capability

Regulatory Compliance AI

21 CFR Part 11 electronic records compliance, GCP audit trail maintenance, and FDA audit readiness scoring built into every output. Constitutional AI governance ensures no output bypasses the compliance layer.

Capability

Clinical Data Analysis

Governed synthesis of cross-system clinical data: EDC, CTMS, lab systems, and safety databases unified into a single auditable intelligence layer. Outputs are typed, citation-bound, and cryptographically traceable to source records.

How It Works

Five-Step Clinical Intelligence Flow

From raw clinical data to a SHA-256 verified, audit-ready intelligence output: every step is governed, traceable, and reproducible.

01

Data Ingestion

Foresight ingests structured and unstructured clinical data from your connected systems: EDC exports, CTMS feeds, FAERS reports, ClinicalTrials.gov, PubMed, and regulatory filings. Every record receives a cryptographic fingerprint at ingestion.

02

Signal Detection

The Signal Intelligence core continuously scans ingested data for adverse event patterns, protocol deviation indicators, competitor regulatory activity, and emerging safety signals. Detections are scored by severity and regulatory exposure level.

03

Governed Analysis

Bounded retrieval reasoning operates only on verified, source-attributed context. No output can be surfaced without a traceable citation chain. Confidence bounds are displayed on all outputs. Human review gates enforce approval at defined clinical decision points.

04

Structured Recommendation

Intelligence outputs are typed and structured: protocol risk assessments, signal escalation reports, regulatory compliance scorecards, and competitive landscape briefs. Each output carries source citations, knowledge cutoff documentation, and governance session ID.

05

Immutable Audit Trail

Every query, every output, and every decision is permanently recorded in a SHA-256 hash-chained evidence ledger. The record is tamper-evident by design and regulator-ready for 21 CFR Part 11 submissions, FDA audits, and GCP compliance reviews.

Compliance Architecture

Built for Regulated Environments

Governance is not a feature added to Foresight. It is the operating foundation. Every compliance standard below is addressed at the architecture layer, not through post-processing or documentation workarounds.

21 CFR Part 11

Electronic records and electronic signatures. Foresight audit trails satisfy FDA requirements for clinical data integrity and electronic record authenticity.

HIPAA-Aware Architecture

Customer-controlled data model. Patient records and PHI remain within your trust boundary and are never used for model training or cross-client inference.

GCP Compliance

Good Clinical Practice documentation standards applied to AI-generated outputs. Every intelligence product is traceable, versioned, and audit-ready for trial inspection.

FDA Audit Readiness

Audit trail format, evidence chain integrity, and output documentation designed to satisfy FDA inspection requirements and respond to 483 observations.

ISO 14155 Support

Clinical investigation of medical devices. Foresight supports the documentation, risk assessment, and protocol review requirements of ISO 14155 compliant trials.

SHA-256 Evidence Chain

Every output is cryptographically fingerprinted. Any output can be verified as unmodified at any point after generation: tamper-evident by design, regulator-ready by architecture.

Validation Documentation Available

All Foresight engagements include a validation documentation package: User Requirements Specification (URS), Functional Requirements Specification (FRS), IQ/OQ/PQ templates, 21 CFR Part 11 compliance matrix, data use prohibition, and audit rights SLA. Bespoke Mentis supports your QA/RA team through the Computer Software Assurance (CSA) process.

Comparison

Foresight vs the Alternatives

Capability
Project Foresight
Manual Processes
Legacy Clinical Systems
Audit-ready output documentation
SHA-256 cryptographic evidence chain
Real-time adverse event signal detectionPartial
21 CFR Part 11 electronic records compliancePartial
Cross-system clinical data unification
AI-assisted protocol optimization
FDA audit readiness scoring
Zero-contamination knowledge cutoffs
Constitutional AI governance layer
Citation-bound intelligence outputsPartial
Who It Serves

Built for Every Tier of Life Sciences

Pharmaceutical Companies

Medical affairs, regulatory affairs, and market access teams at clinical-stage to commercial pharma organizations. Foresight replaces fragmented CI tools and manual protocol review with a single governed intelligence platform.

Contract Research Organizations

CROs managing multi-sponsor trial portfolios need cross-trial signal detection, protocol compliance tracking, and audit-ready documentation at scale. Foresight provides the intelligence infrastructure without the headcount.

Biotech Startups

Early-stage biotech with a single asset and lean teams cannot afford a full CI function. Foresight delivers enterprise-grade intelligence at a fraction of the cost of traditional CI platforms, with governance built in from day one.

Academic Medical Centers

Research institutions conducting investigator-initiated trials need protocol optimization, regulatory compliance support, and signal detection capabilities without dedicated commercial software budgets.

Medical Device Companies

ISO 14155 clinical investigation requirements and FDA 510(k) or PMA submission intelligence. Foresight supports device trial protocol review, adverse event monitoring, and regulatory submission intelligence.

Get Started

Request Pharma AI Demo

Foresight is available for qualified pharmaceutical and biotechnology organizations. Schedule a demo tailored to your therapeutic area and use case. Validation documentation and compliance architecture briefings available on request.

Signal Intelligence Demo
60-minute live session, your therapeutic area
Compliance Architecture Briefing
21 CFR Part 11, GCP, FDA audit readiness
Scoped Pilot Discussion
Single TA, 60-day bounded engagement

Contact for pricing: Scoped Pilot (60-day) · Intelligence Pilot (year one) · Commercial Platform · Constitutional Enterprise

Common Questions

Pharma AI Software: FAQ